Literature DB >> 13687362

Absorption, distribution and retention of the riminocompounds in the experimental animal.

V C BARRY, K BUGGLE, J BYRNE, M L CONALTY, F WINDER.   

Abstract

Keywords:  ANTITUBERCULAR AGENTS/metabolism; TUBERCULOSIS/experimental

Mesh：

Substances：

Year:  1960        PMID： 13687362     DOI： 10.1007/bf02945619

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  10 in total

1.  Uptake by reticulo-endothelial cells of the rimino-phenazine B.663(2-P-chloroanilino-5-P-chlorophenyl-3: 5-dihydro-3-isopropyliminophenazine).

Authors:  M L CONALTY; R D JACKSON
Journal:  Br J Exp Pathol       Date:  1962-12

Review 2.  Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

Authors:  M Gopal; N Padayatchi; J Z Metcalfe; M R O'Donnell
Journal:  Int J Tuberc Lung Dis       Date:  2013-03-25       Impact factor: 2.373

3.  Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.

Authors:  Scott M Irwin; Veronica Gruppo; Elizabeth Brooks; Janet Gilliland; Michael Scherman; Matthew J Reichlen; Rachel Leistikow; Igor Kramnik; Eric L Nuermberger; Martin I Voskuil; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 4.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

5.  Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response.

Authors:  Jason Baik; Kathleen A Stringer; Gerta Mane; Gus R Rosania
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of clofazimine. A review.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

Review 7.  Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies.

Authors:  Thomas J Hwang; Svetlana Dotsenko; Azizkhon Jafarov; Karin Weyer; Dennis Falzon; Kaspars Lunte; Paul Nunn; Ernesto Jaramillo; Salmaan Keshavjee; Douglas F Wares
Journal:  BMJ Open       Date:  2014-01-02       Impact factor: 2.692

8.  Systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a C2 pyridylamino series for the treatment of multidrug-resistant tuberculosis.

Authors:  Binna Liu; Kai Liu; Yu Lu; Dongfeng Zhang; Tianming Yang; Xuan Li; Chen Ma; Meiqin Zheng; Bin Wang; Gang Zhang; Fei Wang; Zhenkun Ma; Chun Li; Haihong Huang; Dali Yin
Journal:  Molecules       Date:  2012-04-17       Impact factor: 4.411

9.  Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates.

Authors:  Sanghee Park; Jihee Jung; Jiyeon Kim; Sang Bong Han; Sungweon Ryoo
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

Review 10.  Chemical Classes Presenting Novel Antituberculosis Agents Currently in Different Phases of Drug Development: A 2010-2020 Review.

Authors:  Klaudia T Angula; Lesetja J Legoabe; Richard M Beteck
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.